Filing Details
- Accession Number:
- 0001209191-19-041754
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-10 19:23:54
- Reporting Period:
- 2019-07-08
- Accepted Time:
- 2019-07-10 19:23:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-07-08 | 20,952 | $56.97 | 212,843 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Common Stock | Disposition | 2019-07-08 | 4,048 | $57.76 | 208,795 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Common Stock | Disposition | 2019-07-09 | 17,200 | $56.27 | 191,595 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Common Stock | Disposition | 2019-07-09 | 7,800 | $57.06 | 183,795 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by the Shak Family Trust |
| No | 4 | S | Indirect | Held by the Shak Family Trust |
| No | 4 | S | Indirect | Held by the Shak Family Trust |
| No | 4 | S | Indirect | Held by the Shak Family Trust |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 5, 2019.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $56.55 to $57.535.
- Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents weighted average sale price. Actual sale prices ranged from $57.555 to $58.01.
- Represents weighted average sale price. Actual sale prices ranged from $55.78 to $56.76.
- Represents weighted average sale price. Actual sale prices ranged from $56.82 to $57.30.
Billionaire Hedge Funds
